Aker BioMarine ASA (OSL:AKBM)
Norway
· Delayed Price · Currency is NOK 60.50
-0.90 (-1.47%)
Jun 6, 2025, 4:29 PM CET
Aker BioMarine ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 201.3 | 199 | 196.3 | 277.2 | 262.1 | 288.59 | Upgrade
|
| Revenue | 201.3 | 199 | 196.3 | 277.2 | 262.1 | 288.59 | Upgrade
|
| Revenue Growth (YoY) | -40.16% | 1.38% | -29.18% | 5.76% | -9.18% | 17.23% | Upgrade
|
| Cost of Revenue | 131 | 129.9 | 123.8 | 162.4 | 174 | 176.03 | Upgrade
|
| Gross Profit | 70.3 | 69.1 | 72.5 | 114.8 | 88.1 | 112.56 | Upgrade
|
| Selling, General & Admin | 59.5 | 61 | 66.4 | 86.5 | 84.3 | 86.85 | Upgrade
|
| Other Operating Expenses | -2.6 | -2 | 0.1 | -4.4 | -2.7 | -0.09 | Upgrade
|
| Operating Expenses | 72.9 | 74.4 | 82.8 | 98.5 | 95 | 103.84 | Upgrade
|
| Operating Income | -2.6 | -5.3 | -10.3 | 16.3 | -6.9 | 8.72 | Upgrade
|
| Interest Expense | -3.8 | -2.5 | -19.7 | -20.3 | -13.7 | -18.74 | Upgrade
|
| Interest & Investment Income | 2.9 | 3.6 | 1.5 | 0.6 | - | 0.88 | Upgrade
|
| Earnings From Equity Investments | - | - | -3 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1 | -1 | -0.8 | 8.1 | 0.6 | -0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.6 | -7.8 | - | -1.7 | -1.7 | 11.83 | Upgrade
|
| EBT Excluding Unusual Items | -12.1 | -13 | -32.3 | 3 | -21.7 | 2.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.4 | 1.31 | Upgrade
|
| Asset Writedown | -1.2 | -1.2 | - | - | -5.8 | -0.04 | Upgrade
|
| Other Unusual Items | - | - | - | 9.2 | 19.7 | -2.98 | Upgrade
|
| Pretax Income | -13.3 | -14.2 | -32.3 | 12.2 | -7.4 | 0.69 | Upgrade
|
| Income Tax Expense | 0.4 | 0.1 | - | 2.2 | 0.6 | 6.15 | Upgrade
|
| Earnings From Continuing Operations | -13.7 | -14.3 | -32.3 | 10 | -8 | -5.46 | Upgrade
|
| Earnings From Discontinued Operations | 202.8 | 194.6 | 23.3 | - | - | - | Upgrade
|
| Net Income | 189.1 | 180.3 | -9 | 10 | -8 | -5.46 | Upgrade
|
| Net Income to Common | 189.1 | 180.3 | -9 | 10 | -8 | -5.46 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 88 | 88 | 88 | 78 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 88 | 88 | 88 | 88 | 78 | Upgrade
|
| Shares Change (YoY) | 2.46% | 0.02% | 0.04% | 0.05% | 12.20% | 13.05% | Upgrade
|
| EPS (Basic) | 2.16 | 2.06 | -0.10 | 0.11 | -0.09 | -0.07 | Upgrade
|
| EPS (Diluted) | 2.16 | 2.06 | -0.10 | 0.11 | -0.09 | -0.07 | Upgrade
|
| Free Cash Flow | -11.9 | -5.2 | 1.5 | -25.4 | -76.1 | -72.7 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -0.06 | 0.02 | -0.29 | -0.87 | -0.93 | Upgrade
|
| Gross Margin | 34.92% | 34.72% | 36.93% | 41.41% | 33.61% | 39.00% | Upgrade
|
| Operating Margin | -1.29% | -2.66% | -5.25% | 5.88% | -2.63% | 3.02% | Upgrade
|
| Profit Margin | 93.94% | 90.60% | -4.58% | 3.61% | -3.05% | -1.89% | Upgrade
|
| Free Cash Flow Margin | -5.91% | -2.61% | 0.76% | -9.16% | -29.04% | -25.19% | Upgrade
|
| EBITDA | 26.3 | 36.6 | 4.5 | 61.1 | 38.5 | 49.75 | Upgrade
|
| EBITDA Margin | 13.06% | 18.39% | 2.29% | 22.04% | 14.69% | 17.24% | Upgrade
|
| D&A For EBITDA | 28.9 | 41.9 | 14.8 | 44.8 | 45.4 | 41.03 | Upgrade
|
| EBIT | -2.6 | -5.3 | -10.3 | 16.3 | -6.9 | 8.72 | Upgrade
|
| EBIT Margin | -1.29% | -2.66% | -5.25% | 5.88% | -2.63% | 3.02% | Upgrade
|
| Effective Tax Rate | - | - | - | 18.03% | - | 894.04% | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.